Skip to main content

Clinical and Translational Oncology

Ausgabe 8/2020

Inhalt (25 Artikel)

Review Article

Maintenance treatment in metastatic colorectal cancer: in search of the best strategy

D. A. Ron, R. Vera, C. M. Labandeira, M. C. Areses Manrique, M. Á. Núñez, N. G. Cid, J. G. Mata, A. F. Montes

Review Article

Breakthrough cancer pain: review and calls to action to improve its management

C. Camps Herrero, N. Batista, N. Díaz Fernández, Y. Escobar Álvarez, A. Gonzalo Gómez, D. Isla Casado, A. Salud, J. Terrasa Pons, V. Guillem Porta

Review Article

An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancer

S. Shamekhi, H. Lotfi, J. Abdolalizadeh, E. Bonabi, N. Zarghami

Open Access Review Article

Organoid of ovarian cancer: genomic analysis and drug screening

H.-D. Liu, B.-R. Xia, M.-Z. Jin, G. Lou

Research Article

IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma

G. Guo, Y. Sun, R. Hong, J. Xiong, Y. Lu, Y. Liu, J. Lu, Z. Zhang, C. Guo, Y. Nan, Q. Huang

Research Article

Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer: a meta-analysis

N. R. Gómez-Hidalgo, P. T. Ramirez, B. Ngo, S. Pérez-Hoyos, N. Coreas, J. L. Sanchez-Iglesias, S. Cabrera, S. Franco, A. P. Benavente, A. Gil-Moreno

Research Article

Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review

D. Viñal, N. Rodriguez-Salas, P. Perez-Wert, O. Higuera, I. Ghanem, J. Feliu

Research Article

Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?

Y. Zhang, C. Ascaso, A. Herreros, J. Sánchez, M. del Pino, A. Torné, Y. Li, S. Sabater, M. Arenas, A. Biete, Á. Rovirosa

Research Article

Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population

D. Viros Porcuna, C. Pollan Guisasola, C. Viña Soria, B. Cirauqui Cirauqui, L. Pardo Muñoz, F. Collurá, R. Mesia Nin

Research Article

Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin

F. Galeano-Valle, G. Pérez-Rus, P. Demelo-Rodríguez, L. Ordieres-Ortega, L. Ortega-Morán, A. J. Muñoz-Martín, S. Medina-Molina, L. A. Alvarez-Sala-Walther, J. del-Toro-Cervera

Research Article

Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer

I. Papageorgiou, J. Dvorak, I. Cosma, A. Pfeil, U. Teichgraeber, A. Malich

Research Article

Survey of treatment recommendations for elderly patients with glioblastoma

M. A. Vaz Salgado, J. Torres, J. Esteban, J. A. Gutiérrez, L. Ley, A. Carrato

Research Article

A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma

F. Pardo, J. Osorio, C. Miranda, S. Castro, M. Miró, A. Luna, E. Garsot, D. Momblán, G. Galofré, J. Rodríguez-Santiago, M. Pera, Maite Santamaria, Eva Artigau, Josep Roig, Juan José Sanchez-Cano, Aurora Aldeano, Mercè GÚell, Josep Feliu, Carles Olona, Carme Balagué

Research Article

Outcomes of vaginal squamous cell carcinoma of patients treated with radiation therapy: a series of 37 patients from a single expert center

E. Romano, S. Janati, L. Monnier, É. Darai, S. Bendifallah, M. Schlienger, E. Touboul, E. Rivin del Campo, F. Huguet

Research Article

Gefitinib promotes CXCR4-dependent epithelial to mesenchymal transition via TGF-β1 signaling pathway in lung cancer cells harboring EGFR mutation

Q. Zhu, Z. Zhang, C. Lu, F. Xu, W. Mao, K. Zhang, H. Shou, Z. Liu, J. Gu, D. Ge

Open Access Research Article

Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

I. Alvarez-Lopez, S. Bezares, E. Dalmau Portulas, E. García-Martínez, J. Á. García-Sáenz, M. Gil-Gil, E. Martínez de Dueñas, N. Ribelles, A. Santaballa Bertrán

Research Article

Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)

J. Valero, P. Peleteiro, I. Henríquez, A. Conde, T. Piquer, A. Lozano, C. C. Soler, J. Muñoz, A. Illescas, J. Jove, M. M. Flores, J. Baquedano, P. Diezhandino, R. P. de Celis, E. H. Pardo, P. Samper, I. Villoslada, M. Eguiguren, V. Millan

Research Article

Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients

S. Cedrés, S. Ponce-Aix, P. Iranzo, A. Callejo, N. Pardo, A. Navarro, A. Martinez-Marti, S. Gómez-Abecia, A. C. Zucchiatti, I. Sansano, A. B. Enguita, J. M. Miquel, C. Viaplana, R. Dienstmann, L. Paz-Ares, E. Felip

Research Article

Adjuvant therapy for true ampullary cancer: a systematic review

M. Bonet, A. Rodrigo, S. Vázquez, V. Carrizo, F. Vilardell, M. Mira

Brief Research Article

Utility of PET/CT in patients with stage I–III melanoma

J. A. Avilés Izquierdo, I. Molina López, P. Sobrini Morillo, I. Márquez Rodas, E. Mercader Cidoncha

Brief Research Article

Current functioning of cardio-oncology units in Spain

C. Mitroi, A. Martín-García, P. Mazón Ramos, J. A. Virizuela Echaburu, M. Arenas-Prat, R. García-Sanz, V. Arrarte Esteban, J. M. García-Pinilla, J. Cosín-Sales, T. López-Fernández

Correspondence

TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM)

A. J. Muñoz Martín, P. Jiménez-Fonseca, A. Carmona-Bayonas, E. Martínez de Castro, J. Muñoz Langa, P. Pérez Segura, A. Rodríguez Lescure, R. Vera García

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.